Status:

COMPLETED

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Immune Thrombocytopenic Purpura

Splenectomy; Status

Eligibility:

All Genders

Brief Summary

The aim of this study is to determine histological immunological parameters, sought on splenectomy pieces that may explain the failure or success of splenectomy in patients with ITP who had a splenect...

Detailed Description

Immune thrombocytopenic purpura (ITP) is a rare autoimmune thrombocytopenia whose incidence is 2 to 5 cases / 100,000 inhabitants / year. The potentially serious haemorrhagic risk is the major issue o...

Eligibility Criteria

Inclusion

  • The analyzed spleens belong to the collection of biological samples declared to the ministry by the Laboratory of Pathology of Haut-Lévêque Hospital (Dr Parrens).

Exclusion

  • Opposition of the patient.

Key Trial Info

Start Date :

April 12 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 30 2015

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04056507

Start Date

April 12 2012

End Date

September 30 2015

Last Update

August 14 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.